Pros | ![]() Beats FD returns for both 3Y & 5Y duration. | |||
Cons | ![]() 5Y returns in the bottom 25% of the category. |
INDMoney rank | 6/8 | |||
Category,Subcateogry | Equity,Sector - Healthcare | |||
Fund Age | 12 Years | |||
Fund Size | 1042 Cr | |||
Min Investment | SIP ₹500 Lumpsum ₹5000 | |||
Expense Ratio | 1.2% | |||
Exit Load | 1% | |||
Benchmark Index | BSE Healthcare TR INR |
No of Holdings | 45 | |||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (11.65%) Cipla Ltd (5.81%) Ajanta Pharma Ltd (4.4%) Dr Reddy's Laboratories Ltd (4.35%) Glenmark Pharmaceuticals Ltd (4.07%) | |||
No of Sectors | 2 | |||
Top 3 Sectors | Health (98.81%) Basic Materials (1.19%) | |||
Equity % | 99.21% | |||
Debt % | - | |||
P/E | 34.71 | |||
P/B | 5.47 | |||
Credit Quality | - | |||
Modified Duration | - | |||
YTM | - |
1-Month Return | 4.21% | |||
3-Month Return | -3.58% | |||
6-Month Return | -6.27% | |||
1-Year Return | 22.13% | |||
3-Year Return | 20.25% | |||
5-Year Return | 23.63% |
Sharpe | 0.84 | |||
Alpha | 0.99 | |||
Beta | 0.95 | |||
Standard Deviation | 16.7 | |||
Information Ratio | 0.18 |
Description | UTI Healthcare Fund-Growth Option- Direct is an equity fund.The fund could potentially beat inflation in the long-run. | |||
Managers | - |